LearnGlossaryMarketStocksSuperinvestorsSign in

INBP

Integrated BioPharma, Inc.

Healthcare · $6M market cap

Verdict

Share price

$0.180

close of Oct 2, 2026

Fair value

$0.158

Sticker Price

Payback Price

$0.063

buy price

Overpriced

INBP is Overpriced: at $0.180 it trades 14% above its fair value of $0.158. Its buy price (Payback Price) is $0.063, 65% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow. There are fewer than 4 years of sales history, too few to confirm a fast-growth phase, so we value it on its free cash flow instead of an earnings forecast.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth36.3% a year✓
Equity per share growth2.8% a year✗
Sales growth2.7% a year✗
Free cash flow growth3.9% a year✗
Return on invested capital-2.9%✗

Follow INBP

Get notified when it reaches its buy price of $0.063. Free.

Create a free account

About Integrated BioPharma, Inc.

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to…

Medical - Pharmaceuticals

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 2, 2026. How the Payback Price works